HCN News & Notes

Massachusetts Prostate Cancer Symposium Slated for June 5

BOSTON — The Massachusetts Prostate Cancer Coalition (MPCC) will bring together today’s leading prostate cancer specialists to provide up-to-date information on the latest in prostate cancer diagnosis, treatment, and research at the 2026 Massachusetts Prostate Cancer Symposium, titled “The Next 25 Years: Early Detection, Equal Access, Enduring Impact.”

The virtual event, moderated by Jordan Rich, host of the MPCC’s “Prostate Cancer & You” podcast, will be held on Friday, June 5 from 8:30 to 11:30 a.m. The event is being held during Men’s Health Month and is free and open to the public.

Centered on MPCC’s 25th anniversary, the symposium will feature sessions highlighting advances in prostate cancer detection, efforts to ensure equitable access to care, and the lasting impact of research and collaboration.

“This symposium brings together world-class experts, survivors, and advocates to help empower our community with the latest information because prostate cancer care continues to evolve. Events like this help ensure that patients and families understand the latest advances and options available to them,” said Dr. J. Jacques Carter, a senior physician at Beth Israel Deaconess Medical Center in Boston, assistant professor of Medicine at Harvard Medical School, and board chair of the MPCC. “By bringing leading specialists together, this event helps make critical prostate cancer information more accessible to our community. We have committed to this for 25 years, and we will continue to make this access to information available and continue to do what we can to help men make informed decisions.”

The event acknowledges the importance of detection, treatments, research, and sharing the latest information to improve outcomes. Presenters at the MPCC Symposium are leading experts, researchers, and professionals dedicated to advancing positive outcomes for individuals affected by prostate cancer.

“I encourage everyone to attend to learn more about prostate cancer screening and understand when to begin screening to maximize the benefit, when screening is appropriate, the screening methods available, and when screening may no longer be necessary,” said Dr. Keyan Salari of Massachusetts General Hospital, a presenter at this year’s symposium.

For information on the speakers and sponsors and to register for the event, visit masspcc.org.